Breaking News

SUN13834 in a mouse model for atopic dermatitis

SUN13834 in a mouse model for atopic dermatitis


The effects of SUN13834, an oral chymase inhibitor, on pruritus were evaluated in a 5-week atopic dermatitis mouse model induced by repeated topical application of 2,4-dinitrofluorobenzene (DNFB). The administration of SUN13834 for 5 weeks was found to inhibit skin swelling and the accumulation of inflammatory cells such as mast cells and eosinophils, and to significantly reduce the scratching behavior at 10 and 50 mg/kg. These findings suggest that SUN13834 may be an effective therapeutic option in atopic dermatitis (Terakawa, M. et. al. Eur J Pharamcol 2008, 601: 186).

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list